IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.08.008

Janyssa Charbonneau , Thomas Couture , Alexis Turgeon , Sarah O'Connor , Jean-François Ouellet , Jean-François Berthin Ouellet , Alexandre Brind’Amour

{"title":"Oncological outcomes of tumor ablation compared to surgical resection in early-stage hepatocellular carcinomas: a systematic review with meta-analysis","authors":"Janyssa Charbonneau , Thomas Couture , Alexis Turgeon , Sarah O'Connor , Jean-François Ouellet , Jean-François Berthin Ouellet , Alexandre Brind’Amour","doi":"10.1016/j.hpb.2024.08.008","DOIUrl":"10.1016/j.hpb.2024.08.008","url":null,"abstract":"<div><h3>Background</h3><div>The optimal choice of treatment for early-stage hepatocellular carcinomas (HCC) remains controversial, with recent conflicted guidelines. This systematic review evaluated whether ablation is oncologically non-inferior to surgical resection.</div></div><div><h3>Methods</h3><div>We performed a systematic search of the EMBASE, MEDLINE, CENTRAL and Web of Science databases to identify randomized controlled trials comparing tumor ablation and surgical resection for early-stage HCCs. A non-inferiority margin of 5% (RR 0.93) for overall survival (OS) was considered, following a consensus of clinical experts.</div></div><div><h3>Results</h3><div>We identified 5829 citations from which 11 trials (n = 1736) were included. The non-inferiority of tumor ablation was not observed for OS (RR 0.92; 95%CI 0.85–1.00,I<sup>2</sup> = 33%). Recurrence-free survival was reduced with ablation (RR 0.80; 95%CI 0.69–0.93,I<sup>2</sup> = 49%). There was no difference in terms of extra-hepatic recurrence and minor complications. Tumor ablation was associated with decreased overall morbidity (RR 0.43; 95%CI 0.30–0.62,I<sup>2</sup> = 31%) and major complications (RR 0.22; 95%CI 0.07–0.71,I<sup>2</sup> = 66%). Intra-hepatic recurrence was higher with ablation (RR 1.28; 95%CI 1.10–1.48,I<sup>2</sup> = 12%). Certainty of evidence was low to moderate.</div></div><div><h3>Conclusion</h3><div>We did not observe the oncological non-inferiority of tumor ablation when compared to surgical resection. Nevertheless, most analyses were of low quality of evidence, including the overall survival. We cannot exclude that the true effect of tumor ablation is different than the currently observed one.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1448-1457"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142180080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Initiation of a robotic pancreatoduodenectomy program using virtual collaboration 利用虚拟协作启动机器人胰十二指肠切除术项目

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.09.001

Alex B. Blair , Kevin C. Soares , Camilla Guerrero , Jeffrey Drebin , William R. Jarnagin , Jin He , Alice C. Wei

{"title":"Initiation of a robotic pancreatoduodenectomy program using virtual collaboration","authors":"Alex B. Blair , Kevin C. Soares , Camilla Guerrero , Jeffrey Drebin , William R. Jarnagin , Jin He , Alice C. Wei","doi":"10.1016/j.hpb.2024.09.001","DOIUrl":"10.1016/j.hpb.2024.09.001","url":null,"abstract":"<div><h3>Background</h3><div>Adoption of robotic pancreatoduodenectomy (RPD) is growing, although there are challenges for safe introduction of this technique, including limitations in on-site expert proctoring. We developed and implemented a structured approach for safe introduction of a new RPD program using virtual collaboration.</div></div><div><h3>Methods</h3><div>A structured framework for introducing a RPD program was designed; key steps included obtaining additional training, identifying required resources, establishing a dedicated team, and patient safety considerations. Virtual collaboration with a proctor for bidirectional communication was utilized for remote operative guidance. In the initial cohort, perioperative data and postoperative outcomes were extracted from a prospectively maintained database.</div></div><div><h3>Results</h3><div>From August 2020 to December 2023, 68 patients underwent RPD. The median operative time was 407 min with an estimated blood loss of 150 mL. Median length of stay was 8 days. Negative margins were obtained in 90% of resections. Operative time was significantly shorter in the second half of cases compared to the first (380min vs 441min, p < 0.01) and rate of conversion decreased (6% vs 21%).</div></div><div><h3>Conclusion</h3><div>The safe initiation of a structured RPD program is feasible through virtual expert collaboration. With careful consideration and an appropriate environment, excellent perioperative outcomes are achievable even for initial cases.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1528-1535"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142180081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysis 经动脉栓塞与化疗栓塞治疗神经内分泌肝转移：倾向匹配分析

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.08.011

Samantha M. Ruff , Jin Y. Chang , Menglin Xu , Aslam M. Ejaz , Mary Dillhoff , Timothy M. Pawlik , Mina S. Makary , Ali Rikabi , Vineeth Sukrithan , Bhavana Konda , Jordan M. Cloyd

{"title":"Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysis","authors":"Samantha M. Ruff , Jin Y. Chang , Menglin Xu , Aslam M. Ejaz , Mary Dillhoff , Timothy M. Pawlik , Mina S. Makary , Ali Rikabi , Vineeth Sukrithan , Bhavana Konda , Jordan M. Cloyd","doi":"10.1016/j.hpb.2024.08.011","DOIUrl":"10.1016/j.hpb.2024.08.011","url":null,"abstract":"<div><h3>Introduction</h3><div>Locoregional therapies are a mainstay of treatment for patients with neuroendocrine liver metastases (NELM), yet the optimal transarterial approach remains undefined and recent studies have raised concern over the safety of transarterial chemoembolization (TACE).</div></div><div><h3>Methods</h3><div>Patients with NELM who underwent TACE or transarterial embolization (TAE) at a single institution between 2000–2022 were retrospectively reviewed. Propensity score matching (PSM) controlling for age, sex, bilateral disease, tumor size, lobar embolization, grade, and extrahepatic disease was utilized to compare short- and long-term outcomes.</div></div><div><h3>Results</h3><div>Among 412 patients with NELM, 329 underwent TACE and 83 TAE. Mean age was 60.7 ± 11.1 years. Patients primarily presented with synchronous (69.2%), bilateral (84.2%), and G1 disease (48.8%) and underwent staged procedures (55.8%). Following PSM, TACE was associated with slightly worse post-procedure laboratory values, but no difference in complications compared to TAE (23.3%vs29.3%, p = 0.247). TACE was associated with improved mean PFS (21.8vs10.7 months, p = 0.002), but no difference in radiographic size, chromogranin level, or median overall survival (50.0 months vs not met, p = 0.833).</div></div><div><h3>Conclusion</h3><div>Among patients with NELM, TACE was associated with similar short-term outcomes and improved PFS, but no difference in OS compared to TAE. These findings highlight the need for additional research on the optimal locoregional therapy for NELM.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1505-1514"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142180085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Highlights in this issue

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/S1365-182X(24)02405-5

引用次数: 0

Prospective cohort study of rotational thromboelastometry in established biliary obstruction: dispelling the myth of auto-anticoagulation 对胆道梗阻患者进行旋转血栓弹性测量的前瞻性队列研究：打破自动抗凝的神话

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.09.005

Angelina Koh , Nicholas Bull , Lisa Brown , Benjamin Thomson , Benjamin Paul Timothy Loveday

{"title":"Prospective cohort study of rotational thromboelastometry in established biliary obstruction: dispelling the myth of auto-anticoagulation","authors":"Angelina Koh , Nicholas Bull , Lisa Brown , Benjamin Thomson , Benjamin Paul Timothy Loveday","doi":"10.1016/j.hpb.2024.09.005","DOIUrl":"10.1016/j.hpb.2024.09.005","url":null,"abstract":"<div><h3>Background</h3><div>Patients with obstructive jaundice are conventionally described as hypocoagulable due to vitamin K malabsorption. However, associated underlying malignancy and synthetic liver dysfunction are mediators of hypercoagulability. The actual effect of biliary obstruction on the coagulation profile is not well characterised. This study aimed to define the coagulation status of patients with established biliary obstruction using rotational thromboelastometry (ROTEM).</div></div><div><h3>Methods</h3><div>This prospective cohort study, conducted in an Australian metropolitan hospital, included patients with a total bilirubin level of >150 umol/L and biliary obstruction on imaging. The primary outcome was the coagulation profile assessed using ROTEM.</div></div><div><h3>Results</h3><div>20 patients were included (median age 74.5 years), 15 were male and 17 had a malignant cause for biliary obstruction. The median bilirubin level was 209 umol/L (IQR: 175.0 umol/L – 255.8 umol/L). On ROTEM, all patients had normal or reduced clot formation times, and normal or increased maximum clot firmness. This confirmed all patients had a normal or hypercoagulable clotting profile, and none were auto-anticoagulated. Vitamin K administration before ROTEM did not vary the coagulation profile.</div></div><div><h3>Discussion</h3><div>Patients with established biliary obstruction and jaundice, predominantly due to malignancy, were normo or hypercoagulable. The belief that obstructive jaundice is associated with a hypocoagulable state should be questioned.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1553-1559"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The use of indocyanine green fluorescence imaging in preventing postoperative bile leakage of the hepaticojejunostomy in robot-assisted pancreatic surgery 吲哚菁绿荧光成像在机器人辅助胰腺手术中预防肝空肠吻合术后胆汁渗漏的应用

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.08.013

Anton F. Gijsen , Roelof P.H. de Vries , Harry G.M. Vaassen , Robert H. Geelkerken , Mike S.L. Liem , Daan J. Lips

{"title":"The use of indocyanine green fluorescence imaging in preventing postoperative bile leakage of the hepaticojejunostomy in robot-assisted pancreatic surgery","authors":"Anton F. Gijsen , Roelof P.H. de Vries , Harry G.M. Vaassen , Robert H. Geelkerken , Mike S.L. Liem , Daan J. Lips","doi":"10.1016/j.hpb.2024.08.013","DOIUrl":"10.1016/j.hpb.2024.08.013","url":null,"abstract":"<div><h3>Background</h3><div>Postoperative bile leakage (POBL) due to insufficiency of the hepaticojejunostomy (HJ) after pancreatico-duodenectomy (PD) is associated with high morbidity and mortality. The aim of this cohort study was to determine the clinical relevance of ICG in detecting and preventing POBL of the HJ in robotic minimal invasive pancreatic surgery (R-MIPS).</div></div><div><h3>Methods</h3><div>All consecutive robot- and ICG-assisted HJ-anastomoses between 2019 and 2022 were included. Biliary leakage was objectified with near infrared technology. Only clinically relevant POBL were considered in this study.</div></div><div><h3>Results</h3><div>Sixty patients who underwent a PD between 2019 and 2022 were included. In ten patients, fluorescence imaging revealed an intra-operative hepaticojejunostomy insufficiency (HJI). Five of these patients developed POBL despite revision but preventing POBL in five patients. Detection of HJI with ICG predicted POBL with a sensitivity and specificity of 41.6% and 89.6% respectively. There was a significant higher chance of developing a POBL if the hepatic duct diameter was less than 5 mm (relative risk = 4.68 (p = 0.0345)), or if an intra-operative HJI was detected (relative risk = 3.57 (p = 0.009)).</div></div><div><h3>Conclusion</h3><div>ICG is a simple and useful tool for detecting intra-operative bile leakage. This study shows that bile illumination with ICG in R-MIPS could prevent postoperative bile leakage.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1515-1520"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142223709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The impact of lymph node ratio on survival in gallbladder cancer: a national cancer database analysis 淋巴结比例对胆囊癌患者生存期的影响：国家癌症数据库分析

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.09.004

Andrii Khomiak, Sumaya A. Ghaffar, Salvador Rodriguez Franco, Ioannis A. Ziogas, Ethan Cumbler, Ana Gleisner, Marco Del Chiaro, Richard D. Schulick, Benedetto Mungo

{"title":"The impact of lymph node ratio on survival in gallbladder cancer: a national cancer database analysis","authors":"Andrii Khomiak, Sumaya A. Ghaffar, Salvador Rodriguez Franco, Ioannis A. Ziogas, Ethan Cumbler, Ana Gleisner, Marco Del Chiaro, Richard D. Schulick, Benedetto Mungo","doi":"10.1016/j.hpb.2024.09.004","DOIUrl":"10.1016/j.hpb.2024.09.004","url":null,"abstract":"<div><h3>Background</h3><div>The study aimed to investigate the impact of lymph node ratio (LNR) on survival in patients with resectable gallbladder adenocarcinoma.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed the National Cancer Database from 2004 to 2020. We included patients with gallbladder adenocarcinoma who had undergone resection of the primary site as well as adequate lymphadenectomy. Exclusions comprised patients with distant metastasis and missing key data. LNR was calculated as a proportion of positive lymph nodes (LNs) to examined LNs.</div></div><div><h3>Results</h3><div>Patients were stratified into LNR groups: LNR0 - 343 patients (55%); 168 (26.9%) patients with LNR < 30%; and 113 (18.1%) with LNR ≥ 30%. The mean age was 67.3 ± 10.7 years, with 71.6% being female and 75.8% identifying as white. The mean overall survival (OS) was 52.8 months for the LNR0 group, 36.3 months for LNR < 30%, and 27 months for LNR ≥ 30% (p < 0.001). The difference in survival was significant when adjusted for adjuvant chemotherapy status and surgical margins using Cox regression – HR 3.2 (2.4–4.5 95% CI) for LNR < 30% and HR 4.9 (3.5–6.8 95% CI) for LNR ≥ 30%.</div></div><div><h3>Conclusion</h3><div>The study suggests that LNR is a valuable prognostic factor for resectable gallbladder cancer patients and could potentially guide treatment decisions.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1544-1552"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rescue pancreatic duct occlusion as pancreas-preserving procedure in case of emergency relaparotomy for grade C pancreatic fistulas after pancreaticoduodenectomy 胰十二指肠切除术后 C 级胰瘘紧急再剖腹手术中作为保胰手术的胰管闭塞抢救术

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.08.012

Davide Citterio, Marianna Maspero, Isabella Pezzoli, Michele Droz Dit Busset, Jorgelina Coppa, Carlo Sposito, Vincenzo Mazzaferro

引用次数: 0

Artisential®-assisted pancreatoduodenectomy: a comparative analysis with Robot(Da Vinci®)-assisted pancreatoduodenectomy Artisential®辅助胰十二指肠切除术：与机器人（达芬奇®）辅助胰十二指肠切除术的比较分析。

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.09.006

Su Hyeong Park , Seoung Yoon Rho , Munseok Choi , Seung Soo Hong , Sung Hyun Kim , Chang Moo Kang

{"title":"Artisential®-assisted pancreatoduodenectomy: a comparative analysis with Robot(Da Vinci®)-assisted pancreatoduodenectomy","authors":"Su Hyeong Park , Seoung Yoon Rho , Munseok Choi , Seung Soo Hong , Sung Hyun Kim , Chang Moo Kang","doi":"10.1016/j.hpb.2024.09.006","DOIUrl":"10.1016/j.hpb.2024.09.006","url":null,"abstract":"<div><h3>Background</h3><div>Robot-assisted pancreaticoduodenectomy (R-PD) helps further improve the safety and efficacy of minimally invasive pancreaticoduodenectomy. However, it faces challenges such as high costs and limitations in availability at different centers, making it difficult for patients to access. In this study, we evaluate the initial experience of Artisential®-assisted PD (A-PD) and compare its perioperative outcomes with R-PD, discussing the clinical applicability of A-PD.</div></div><div><h3>Methods</h3><div>This study reviewed cases of R-PD and A-PD conducted between 2022 and 2023. A total of 34 patients underwent R-PD, while 26 patients underwent A-PD. Statistical analysis was conducted based on factors related to the patient's surgical procedure and postoperative prognostic indicators.</div></div><div><h3>Results</h3><div>There were no significant differences observed between the two groups in terms of surgical factors. There were also no differences in the occurrence of postoperative complications. However, there was a significant difference in the length of hospital stay, with the Artisential® group having an average of 11.50 ± 5.54 days and the Robot group having 15.06 ± 5.34 days (p = 0.001).</div></div><div><h3>Conclusions</h3><div>R-PD and A-PD showed no differences in procedures or outcomes. Using a multi-articulated device is beneficial where robot use is challenging.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1477-1486"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma 胰腺导管腺癌患者接受新辅助化疗后肿瘤病理反应良好的相关因素

IF 2.7 3区医学

Hpb Pub Date : 2024-12-01 DOI: 10.1016/j.hpb.2024.09.002

James M. Halle-Smith , Prudence Leung , Lewis Hall , Merve Aksin , Stijn van Laarhoven , James Skipworth , Nikolaos Chatzizacharias , Rachel M. Brown , Keith J. Roberts

{"title":"Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma","authors":"James M. Halle-Smith , Prudence Leung , Lewis Hall , Merve Aksin , Stijn van Laarhoven , James Skipworth , Nikolaos Chatzizacharias , Rachel M. Brown , Keith J. Roberts","doi":"10.1016/j.hpb.2024.09.002","DOIUrl":"10.1016/j.hpb.2024.09.002","url":null,"abstract":"<div><h3>Introduction</h3><div>Pathological response of pancreatic ductal adenocarcinoma (PDAC) to neoadjuvant chemotherapy (NAT) has been associated with oncological outcome. The aim of the study was to investigate factors associated with favourable tumour regression in patients undergoing pancreatic resection for PDAC.</div></div><div><h3>Methods</h3><div>Patients who received NAT before undergoing PDAC resection at two institutions were reviewed. Tumour regression grading (TRG) was scored according to the College of American Pathologists (CAP) system. Interactions between chemotherapy, tumour and surgical factors with TRG were explored.</div></div><div><h3>Results</h3><div>54 patients were identified, with 12 (22%) displaying a favourable response to NAT. The type of chemotherapy agent received, the number of cycles or a dose reduction during NAT course was not significantly different between the groups<strong><em>.</em></strong> The time from diagnosis to chemotherapy and time from end of chemotherapy to surgery were also similar between the groups. A favourable TRG was associated with greater disease-free survival median 33.2 months vs. 10.3 months; p = 0.0) but not overall survival (median 43.8 months vs. 32.3 months; p = 0.200), which may be due to small sample size.</div></div><div><h3>Conclusions</h3><div>Chemotherapy factors were not significantly related to a favourable response to NAT. Future studies should seek to identify modifiable factors associated with a favourable TRG.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"26 12","pages":"Pages 1536-1543"},"PeriodicalIF":2.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142264587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hpb最新文献